LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 292 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,623,777 | -3.9% | 43,788 | +15.6% | 0.00% | 0.0% |
Q2 2023 | $2,730,571 | +15.0% | 37,872 | -47.6% | 0.00% | 0.0% |
Q1 2023 | $2,374,914 | +16.5% | 72,295 | +136.9% | 0.00% | 0.0% |
Q4 2022 | $2,038,135 | -21.6% | 30,511 | +1.1% | 0.00% | 0.0% |
Q3 2022 | $2,600,000 | +9.5% | 30,189 | +13.4% | 0.00% | 0.0% |
Q2 2022 | $2,375,000 | -10.3% | 26,618 | +13.1% | 0.00% | 0.0% |
Q1 2022 | $2,647,000 | -20.6% | 23,528 | +9.0% | 0.00% | -50.0% |
Q4 2021 | $3,334,000 | +48.2% | 21,583 | +33.6% | 0.00% | +100.0% |
Q3 2021 | $2,250,000 | +13.5% | 16,153 | +6.8% | 0.00% | 0.0% |
Q2 2021 | $1,983,000 | +27.9% | 15,118 | +48.7% | 0.00% | 0.0% |
Q1 2021 | $1,550,000 | +15.7% | 10,168 | -24.5% | 0.00% | 0.0% |
Q4 2020 | $1,340,000 | -39.1% | 13,476 | -41.6% | 0.00% | -50.0% |
Q3 2020 | $2,200,000 | -3.3% | 23,083 | +13.5% | 0.00% | 0.0% |
Q2 2020 | $2,275,000 | +55.0% | 20,338 | +0.7% | 0.00% | 0.0% |
Q1 2020 | $1,468,000 | -13.1% | 20,189 | +24.6% | 0.00% | 0.0% |
Q4 2019 | $1,689,000 | -15.7% | 16,197 | -19.6% | 0.00% | 0.0% |
Q3 2019 | $2,004,000 | -15.7% | 20,134 | -3.3% | 0.00% | -33.3% |
Q2 2019 | $2,377,000 | +6.5% | 20,826 | +17.3% | 0.00% | 0.0% |
Q1 2019 | $2,232,000 | +17.0% | 17,752 | +26.3% | 0.00% | 0.0% |
Q4 2018 | $1,907,000 | +59.4% | 14,050 | +143.1% | 0.00% | 0.0% |
Q2 2018 | $1,196,000 | +23.6% | 5,779 | -2.0% | 0.00% | 0.0% |
Q1 2018 | $968,000 | +5.0% | 5,899 | -12.4% | 0.00% | +50.0% |
Q4 2017 | $922,000 | +1.9% | 6,732 | +1.2% | 0.00% | 0.0% |
Q3 2017 | $905,000 | +27.6% | 6,655 | +13.8% | 0.00% | 0.0% |
Q2 2017 | $709,000 | +16.2% | 5,847 | +1.5% | 0.00% | 0.0% |
Q1 2017 | $610,000 | +10.7% | 5,762 | +5.9% | 0.00% | 0.0% |
Q4 2016 | $551,000 | +12.0% | 5,443 | +12.9% | 0.00% | 0.0% |
Q3 2016 | $492,000 | -18.8% | 4,823 | -5.1% | 0.00% | 0.0% |
Q2 2016 | $606,000 | +17.4% | 5,084 | +5.5% | 0.00% | 0.0% |
Q1 2016 | $516,000 | +19.2% | 4,818 | +20.6% | 0.00% | 0.0% |
Q4 2015 | $433,000 | +50.9% | 3,996 | +19.2% | 0.00% | +100.0% |
Q3 2015 | $287,000 | +39.3% | 3,353 | +63.9% | 0.00% | 0.0% |
Q2 2015 | $206,000 | +795.7% | 2,046 | +373.6% | 0.00% | – |
Q4 2014 | $23,000 | +21.1% | 432 | +7.2% | 0.00% | – |
Q3 2014 | $19,000 | +58.3% | 403 | +111.0% | 0.00% | – |
Q2 2014 | $12,000 | +71.4% | 191 | +87.3% | 0.00% | – |
Q1 2014 | $7,000 | – | 102 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |